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Targeting Gene Expression Relevant to DNA Replication 
Apparatus
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Abstract: Using real-time RT-PCR and Western blot analysis in bovine kidney epithelial cells, we systematically investigated 
the effects of butyrate on patterns of gene expression relevant to DNA replication apparatus. The real-time PCR and West-
ern blot data generally conﬁ  rmed previously reported microarray data. Of the ﬁ  ve genes tested by quantitative RT-PCR, 
CDKN1A (p21
waf1) was up regulated, CDC2/cdk1, MCM6, ORC1L were down regulated, while ORC3L expression remained 
unchanged following butyrate treatment. Also consistent with RT-PCR results, Western blot analysis conﬁ  rmed that butyr-
ate up-regulated cyclin-kinase inhibitor p21
waf1 in a does-dependent manner. In contrast, butyrate treatment had no effect 
on the expression of ERK 1/2 proteins. Also consistent with mRNA results, ORC1 and MCM3 proteins were down-regulated 
by butyrate treatment, while ORC2 protein remained unchanged. The present results suggest that ORC1, not ORC2 or 
ORC3, along with MCM proteins play a critical role in regulating the initiation of DNA replication and cell cycle progres-
sion in MDBK cells and are targets of butyrate regulation.
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Introduction
In cattle, few deﬁ  nitive studies, if any at all, have sought to address the capabilities of nutrients to 
modulate gene expression and proteomic outcomes as a means of arresting metabolic stress. Short-chain 
fatty acids (SCFAs, i.e. acetate, propionate, and butyrate) are formed during microbial fermentation of 
dietary ﬁ  ber in the gastrointestinal tract of mammalian species and then are directly absorbed at the site 
of production. SCFAs contribute up to 70% of the energy requirements of ruminants (Bergman, 1990). 
Although acetate and propionate hold a prominent position in providing energy to ruminant metabolism, 
butyrate, which is present in relative low concentrations, seems to be involved in metabolism beyond 
its role as a nutrient. Ruminant species metabolize SCFAs to fulﬁ  ll up to 70% of their nutrient energy 
requirements. Beyond their nutritional impact; SCFAs, especially butyrate, modulate cell differentia-
tion, proliferation, motility, and in particular, induce cell cycle arrest and apoptosis. However, a major-
ity of previous studies were focused on the cancer therapeutic potential of butyrate and thus used 
cancer cell lines as research models (Myzak and Dashwood, 2006). The cell cycle regulatory effects of 
butyrate at the cellular and molecular levels in normal bovine cells have not been studied thus far, but 
would serve as a principle launching point to validate the need for further study of this phenomena in 
cattle. Because short-chain fatty acids are common nutrients, understanding their important biological 
functions additional to a simple energy supply will certainly help us to understand critical control points 
in the cell cycle that could lead to improvements in the efﬁ  cient production of food animals. For 
example, during periods of naturally encountered stresses, such as the weaning period when production 
and uptake of short-chain fatty acids are signiﬁ  cantly increased, short-chain fatty acids-induced apop-
tosis and cell cycle arrest may affect growth slumps of young cattle. Minimizing the duration of growth 
slumps has the potential to affect the industry signiﬁ  cantly. In addition, MDBK as an established bovine 
cell line with inducible apoptosis and cell cycle regulatory events certainly is ideal and an invaluable 
tool for functional genomic studies on homeostasis in animals.
1Mention of trade names or commercial products in this publication is solely for providing speciﬁ  c information and does not imply recommendation or 
endorsement by the U.S. Department of Agriculture.114
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At physiologic concentration, butyrate regulates 
the expression of individual genes using at least 
three different mechanisms: (1) through induction 
of cis- and trans-acting butyrate-dependent tran-
scription factor for selected genes, (2) by inhibi-
tion of histone deacetylation and attendant 
chromatin remodeling and (3) by affecting 
turnover of mRNAs (Parab et al. 2007; Myzak 
et al. 2006). The major biochemical change that 
occurs in cells treated with butyrate and other 
histone deacetylase (HDAC) inhibitors is the 
global hyperacetylation of histones (Riggs et al. 
1977). In our previous studies, a normal bovine 
kidney epithelial cell line (Madin-Darby bovine 
kidney; MDBK) was used to investigate the cell 
cycle regulatory and apoptotic effects of butyrate. 
Butyrate not only induced apoptosis but also 
induced cell cycle arrest at the G1/S boundary in 
MDBK cells. We used sodium butyrate, an impor-
tant nutrition component for cattle and a histone 
deacetylase inhibitor to show that butyrate treat-
ment was able to stop MDBK cell proliferation 
and cells undergo G1/S arrest. Our data also indi-
cated that DNA replication was blocked at a very 
early stage of S-phase by butyrate treatment (Li 
and Elsasser, 2005). Since butyrate blocks cell 
cycle progression at very early stage of S-phase, 
it is reasonable to assume that genes directly 
related to initiation and regulation of DNA repli-
cation and cell cycle progression may be targeted 
by butyrate. Using high-density microarrays to 
examine the global gene expression and global 
gene expression proﬁ  les of the bovine kidney 
epithelial cells, we discovered 450 genes that were 
signiﬁ  cantly regulated by butyrate with a median 
False Discovery Rate (FDR) = 0%. The majority 
of these genes was repressed by butyrate and was 
associated with cell cycle control (Li and Li, 
2006). The microarray data is available as acces-
sion GSE3970 in the Gene Expression Omnibus 
repository at the National Center for Biotechnology 
Information (http://www.ncbi.nlm.nih.gov/geo/).
Cell-cycle arrest at G1 phase induced by butyr-
ate suggests that a common responding element in 
genes responsive to the treatment of butyrate is 
required for progression of phase G1. This observa-
tion is also consistent with the previous report that 
the inhibition of G1 progression by butyrate is not 
restricted to a speciﬁ  c mitogenic signaling pathway 
(Charollais et al. 1990), but may also include the 
inhibitory effect on initiation of DNA replication. 
Especially, the effects of butyrate on patterns of 
gene expression relevant to DNA replication 
apparatus are probably the causes of inhibition of 
initiation of DNA replication. To determine the 
epigenetic effects of physiologic concentrations of 
butyrate on cellular level of proteins, which are the 
putative targets of butyrate induced cell cycle arrest, 
our effort in this study was focused on the initiation 
of DNA replication apparatuses regulated by 
butyrate. We systematically investigated the expres-
sion regulation of the DNA replication regulatory 
genes by butyrate using both real-time RT-PCR and 
Western blot analysis in bovine kidney epithelial 
cells. Our results conﬁ  rmed and extended our earlier 
ﬁ  ndings of butyrate-regulated gene expression in 
our earlier publication (Li and Li, 2006). The 
present results suggest that ORC1, not ORC2 or 
ORC3, along with MCM proteins play a critical 
role in regulating the initiation of DNA replication 
and cell cycle progression in MDBK cells.
Materials and Methods
Cell culture and cell treatments
The Madin-Darby bovine kidney epithelial cells 
(MDBK, American Type Culture Collection, 
Manassas, VA., and Catalog No. CCL-22) were 
cultured in Eagle’s minimal essential medium 
supplemented with 5% fetal bovine serum (Invit-
rogen, Carlsbad, C.A) in 25 cm
2 ﬂ  ask with medium 
renewal twice per week. Cell cultures were main-
tained in a water-jacked incubator with 5% CO2 at 
37 ºC. Sub-cultivations were performed when cells 
attained 80 to 90% conﬂ  uence, according to the 
product information supplied by American Type 
Culture Collection. Cells were used for treatment 
testing at approximately 50% conﬂ  uence, during 
the exponential phase of growth.
Sodium butyrate (Calbiochem, San Diego, C.A) 
was prepared as 1 M stock by dissolving it in ultra 
pure de-ionized water (tissue culture grade, 
Advanced Biotechnologies Inc., Columbia, MD). 
Final concentrations of sodium butyrate treatment 
ranged from 2.5 to 10 mM. Adding up to 10 mM 
sodium butyrate into cell culture medium did not 
cause measurable pH changes. Each treatment was 
performed in duplicate. After 24 hours of sodium 
butyrate treatment, cells were collected by 
trypsinization. Viability of cells was determined 
by Trypan Blue stain exclusion (Invitrogen).
5-Bromo-2’-deoxyuridine (BrdU) incorporation 
labeling and Flow cytometric analysis of cells.115
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Cells were labeled with BrdU using BrdU 
Flow kits (BD Pharmingen, San Diego, C.A). To 
pulse label the cells, 10 µl of BrdU solution 
(1 mM BrdU in PBS) was carefully added directly 
to each ml of culture media and cultured for 40 min. 
To immunofluorescent stain cells, cells were 
collected with trypsinization, ﬁ  xed, and permeabi-
lized with BD Cytoﬁ  x/Cytoperm buffer, supplied 
with the kits. Cells were then treated with DNase 
to expose incorporated BrdU (30 µg of DNase to 
each sample, incubated at 37 ºC for 1 hour). After 
washing with 1 ml of 1X BD Perm/wash buffer, 
cells were resuspended with 50 µl of BD Perm/
Wash buffer containing diluted ﬂ  uorescent (Fluo-
rescent isothiocyanate, FITC) anti-BrdU antibody 
and incubated for 20 min at room temperature. After 
washing with BD Perm/Wash buffer, cells were 
resuspended in 20 µl of 7-AAD solution (supplied 
with kits) to stain the cellular DNA content. The 
amount of DNA was measured by the amount of 
dye taken up by the cells and indirectly by the DNA 
content. Flow cytometric analyses were performed, 
using a ﬂ  ow cytometry (FC500, Beckman Coulter 
Inc., Palatine, IL) and collected data was analyzed 
using Cytomics RXP (Beckman Coulter Inc.). At 
least 10,000 cells per sample were analyzed.
Real-time RT-PCR
Real-time RT-PCR analysis was carried out with 
the IQ SYBR Green Supermix kit (Biorad) using 
200 nM of each ampliﬁ  cation primer Table 1 and 
the 1st-strand cDNA (100 ng of the input total RNA 
equivalents) in a 25 µl reaction volume. The ampli-
ﬁ  cation was carried out on an iCycler iQ
TM Real 
Time PCR Detection System (BioRad) with the 
following proﬁ  le: 95 
oC–60s; 40 cycles of 94 
oC–15s, 60 
oC –30s, and 72 
oC–30s. The melting 
curve analysis was performed for each primer pair. 
Expression levels of β-actin remained constant 
(within 0.5 Ct between samples) and were used as 
endogenous controls. Relative gene expression 
data was calculated using the 2
−∆∆CT method (Livak 
and Schmittgen, 2001).
Preparation of cell extracts 
and western blot analyses
Cells were collected from culture ﬂ  asks by tryp-
sinization. Cells were then washed with com-
plete medium including a 5% fetal bovine serum, 
and followed by PBS twice. Cells were extracted 
with 10 volumes of M-PER (Mammalian Protein 
Extraction Reagent, Pierce Biotechnology, 
Rockford, IL) supplemented with 150 mM NaCl 
and protease inhibitor cocktail (Protease inhibi-
tor cocktail tablets, Boehringer Mannheim, 
GmbH, Germany) and then incubated on ice for 
10 min before centrifugation (1500 g, 5 min at 
4 ºC in Eppendorf microfuge) to eliminate 
debris. SDS-PAGE was done in a 4 to 20% gra-
dient polyacrylamide gel (Invitrogen) under the 
reducing conditions suggested by the manufac-
turer. Pre-stained molecular weight standards 
were included (SeeBlue-plus2, Invitrogen). 
Separated proteins were transferred to pure 
nitrocellulose membrane (Protran, 0.2 µm, 
Schleicher and Schuell, Dassel, Germany). 
Western blot analyses were performed using 
anti- cdc6 antibody, anti-acetyl histone3 (H3), 
and anti p21 antibody (Cell Signaling Technol-
ogy, Beverly, MA). Secondary antibodies used 
were horseradish peroxidase-conjugated anti-
mouse or anti-rabbit IgG antibodies (Pierce 
Biotechnology, Rockford, IL). Membranes were 
blocked ﬁ  rst with 5% of fat-free dry milk in PBS 
for one hour and followed by incubation with 
antibodies speciﬁ  ed (1:2000 diluted in PBS plus 
0.1% Triton 100). Membranes were then washed 
ﬁ  ve times with PBS containing 0.1% Triton 100. 
Secondary antibodies (1:25000 diluted with PBS 
plus 0.1% Triton 100) were added and incubated 
Table 1. Primers Used in Real-Time RT-PCR.
Accession Gene Symbols Forward Reverse
NM_174016 CDC2 TTCATGGGGATTCAGAAATTG TTTCGAGAGCAGATCCAAG
NM_001046234 MCM6 TCAAGAAGAAGATGCCCAGATG AGCCCAGCCTCAAGGAAG
TC293949 ORC1L AGGAAGCAACATTTCAACAG AGCATACAGCACATCATCC
NM_001038139 ORC3L CCTTCGCCAACACCTGAATG CCTCCGACCAGTCCACAAG
NM_001098958 CDKN1A GCCCTTTCCCCTTAGTATCTTC GTCGCTGCTTGAGGTAGAAC
NM_173979 ACTB CCACCCCGCTTCTCTCTAAG AATTTACACAAAAGCGATCACCTC116
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Results
Butyrate induces cell cycle arrest and 
hyperacetylation of histone 3 in 
MDBK cells
We previously reported butyrate induced cell cycle 
arrest in MDBK cells (Li and Elsasser, 2005). Prior 
to mRNA and protein analysis, the butyrate induced 
cell cycle arrest was reconﬁ  rmed. As shown in the 
Figure 1A, after butyrate treatment for 24 h, cell 
population proﬁ  les changed signiﬁ  cantly. Cells 
in S-phase were almost completely eliminated in 
10 mM butyrate treated cell populations. This result 
conﬁ  rmed our prior observation that cells were 
arrested at the G1/S boundary and DNA replication 
was blocked by butyrate treatment. We also 
conﬁ  rmed the accumulation of acetylated histone 
3 (H3) due to butyrate treatment (Fig. 1B). 
Monoclonal antibody against acetyl H3 was used 
to evaluate the histone deacetylase inhibitory 
activity of butyrate. As shown in Figure 1B, butyr-
ate treatment induced accumulation of acetyl H3 
in a does-dependent manner.
Validation of microarray data 
by quantitative RT-PCR
Previous microarray data (Li and Li, 2006), 
indicated that butyrate induced signiﬁ  cant changes 
in mRNA expression of genes directly involved in 
DNA replication (Table 2). DNA microarray 
analysis measures expressional changes in thou-
sands of transcripts, and therefore, the statistical 
evaluation of this data is prone to type I errors (false 
positive results). We identiﬁ  ed genes signiﬁ  cantly 
regulated by sodium butyrate at a very stringent 
false discovery rate (FDR) = 0%. However, 
Figure 1A. Cell population proﬁ  les determined by ﬂ  ow cytometry. 
For ﬂ  ow cytometric analysis, cells were ﬁ  rst pulse labeled with BrdU 
for 30 min. Collected cells were ﬁ  rst stained with diluted ﬂ  uorescent 
(Fluorescent isothiocyanate, FITC) anti-BrdU antibody and then 
stained with DNA marker (7-ADD). The ﬂ  uorescent signal generated 
by FITC was acquired in a logarithmic mode, and ﬂ  uorescent signal 
from the DNA-content marker 7-ADD was normally acquired in the 
linear signal ampliﬁ  cation mode. Cells were separated into three 
clusters by double staining analysis. A) G1/G0 cells, with 2C DNA 
content and without any DNA synthesis activity; B) S phase cells, 
with DNA content between 2C and 4C (two and four copies of DNA 
content respectively), and high BrdU incorporation (DNA synthesis) 
activity C) G2/M cells, with 4C DNA content and also without DNA 
synthesis activity.
Figure 1B. Butyrate induced hyperacetylation of histone 3 (H3). This 
ﬁ  gure is representative of three experiments. Protein from different 
samples was separated by SDS PAGE on two identical 4 to 20% 
polyacrylamide gradient gels. One gel was stained with SimpleBlue 
(Invitrogen) and one was transferred to a membrane for Western 
blotting with monoclonal anti- acetyl H3 antibodies.
for one hour. Membranes were washed 5 times 
with PBS containing 0.1% Triton 100. Immu-
noblots were exposed to SuperSignal West Pico 
Stable Peroxide solution with a luminol/enhancer 
(Pierce Biotechnology) according to the manu-
facturer’s instruction. Western blots were then 
scanned and analyzed using UN-SCAN_IT gel 
(V 61, Silk Scientiﬁ  c) to quantify the density of 
the bands.117
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we think that validation of the initial microarray 
data by quantitative RT (reverse transcriptase)-
PCR is necessary, wherever possible. The real-time 
PCR data generally confirmed the microarray 
analysis. Linear regression analysis demonstrated 
a strong positive correlation between the two tech-
nological platforms. Of ﬁ  ve genes that we tested, 
CDKN1A (p21) was up regulated by butyrate, 
CDC2/cdk1, MCM6, ORC1L were down regu-
lated, while ORC3L remained unchanged upon 
butyrate treatment.
Protein expression analysis
A selection of proteins was examined using 
Western blot analysis based on availability of 
antibodies that recognize bovine proteins. These 
selected proteins included products of cell cycle 
regulatory genes such as p21, CDC2/CDK1, as 
well as proteins from DNA replication apparatus 
such as ORC1, ORC2 and MCM3. Overall there 
was a high correlation between mRNA and pro-
tein expression for all proteins analyzed. First, 
we examined cell cycle regulatory protein cdc6 
Table 2. Butyrate Down-regulated genes which products are directly related to initiation of DNA replication*.
Hugo gene 
symbol
Description Mean fold 
change (n = 3)
False discovery 
rate, q-value
Location Family
CDC2/CDK1 Cell division 
cycle 2, G1 to S 
and G2 to M
−8.217 0 Nucleus kinase
MCM2 MCM2 minichro-
mosome main-
tenance 
deﬁ  cient 2, mito-
tin (S. cerevi-
siae)
−7.183 0 Nucleus enzyme
MCM3 MCM3 minichro-
mosome main-
tenance 
deﬁ  cient 3 (S. 
cerevisiae)
−10.3 0 Nucleus enzyme
MCM4 MCM4 minichro-
mosome main-
tenance 
deﬁ  cient 4 (S. 
cerevisiae)
−7.226 0 Nucleus enzyme
MCM5 MCM5 minichro-
mosome main-
tenance 
deﬁ  cient 5, cell 
division cycle 46 
(S. cerevisiae)
−6.002 0 Nucleus enzyme
MCM6 MCM6 minichro-
mosome main-
tenance 
deﬁ  cient 6 
(MIS5 homolog, 
S. pombe) (S. 
cerevisiae)
−11.618 0 Nucleus enzyme
ORC1L Origin recogni-
tion complex, 
subunit 1-like 
(yeast)
−4.368 0 Nucleus other
*Data was extracted from microarray experiment, (Li and Li, 2006; Li et al. 2006).118
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and cdc2. As shown in Figures 2A and 3A, 
butyrate down-regulated CDC6 and CDC2/CDK1 
in addition to ORC1 and MCM2 protein levels. 
Both of which were consistent with RT-PCR 
results. Interestingly, ORC2 protein expression 
did not change as a result of butyrate treatment. 
Since RT-PCR also conﬁ  rmed that expression of 
ORC3 did not change upon butyrate treatment 
and only ORC1 mRNA was detected by microar-
ray to be down-regulated by butyrate, it is reason-
able to assume that among six subunits of ORC, 
ORC1 is the only gene was targeted by butyrate. 
We also synchronized cells using the serum star-
vation approach and monitored ORC1 protein 
expression. Under all three conditions (normal 
growing cells, cells synchronized at G1/G0 
boundary and S phases), sodium butyrate 
inhibited ORC1 protein expression (Fig. 3B), 
suggesting the anti-proliferative and pro-apop-
totic effects of butyrate were independent of cell 
cycle status. By comparison of Figure 2A and 
Figure 3A, decreasing levels of CDC6 and CDC2 
are much deeper than ORC1 and MCM3. We 
suspect that the proteasome-dependent degrada-
tion of CDC6 and CDC2 may play some role as 
reported in an earlier study (Li and Elsasser, 
2005). Finally, we tested and examined the 
protein level of p21
waf1 and also examined the 
protein level of p21
waf1, a negative gene expres-
sion regulatory gene. Butyrate up-regulated the 
cyclin-kinase inhibitor p21
waf1 in a dose-
dependent manner (Fig. 4). In contrary, butyrate 
treatment has no effect on expression levels of 
ERK 1/2 proteins.
Figure 2. Butyrate treatment induced down regulation of cell cycle regulatory proteins cdc6 and cdc2/cdk1. Butyrate treated cells were 
extracted and proteins were separated on SDS PAGE. Western Blot analyses were performed with antibody against cdc6 and cdc2/cdk1. 
Western Blots from three experiments were quantiﬁ  ed with UN-SCAN-IT software (Silk Scientiﬁ  c, Orem, Utah. U.S.A). The relative densities 
were measured and corrected with the protein density. Density of control band is presented as 100% (n = 3 per treatment). Data was sta-
tistically analyzed by ANOVA using GraphPad Prism 4.00 for Windows (GraphPad Software, San Diego, C.A., U.S.A). Data is presented as 
means +/− SEM.119
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Discussion
The results we present here provide evidence for a 
direct link between the initiation of DNA replication 
and the cell growth regulatory pathways involving 
cell cycle progression. Initiation of eukaryotic DNA 
replication depends on the function of pre-replication 
complexes (pre-RC), one of its key components 
being the six subunits of the origin recognition 
complex (ORC). Eukaryotic DNA replication is a 
highly conserved process that begins with binding 
of a six-subunit ORC to DNA (Bell and Dutta, 
2002). Proteins Cdc6 and Cdt1 (also called RLF-B) 
then load Mcm proteins 2 to 7 onto these ORC-
chromatin sites to form pre-replication complexes 
(pre-RCs). MCM2 to MCM7 hexamers constitute 
the helicases that unwind the DNA. Pre-RCs are 
activated upon binding of Mcm10 protein 
(Wohlschlegel et al. 2002). CDC6 is then released 
by the cyclin-dependent protein kinase CDK2/
cyclin A and replaced by CDC45 with the help of 
the protein kinases CDC7/Dbf4 and CDK2/cyclin 
E. DNA polymerase-DNA primase, which is 
escorted to the complex by Cdc45, then initiates 
RNA-primed DNA synthesis (S phase).
Recently, utilizing gene expression proﬁ  ling, 
our studies indicated that butyrate induces many 
signiﬁ  cant changes in the expression of genes 
associated with regulatory pathways that are 
critical to cell growth, immune response and sig-
nal transduction (Li and Li, 2006). Using the 
Ingenuity Pathway Knowledge base (Ingenuity® 
Systems, www.ingenuity.com), the functional 
category and pathway analysis of differential 
expressed genes in cells treated with butyrate were 
explored. The functional category and pathway 
analyses of the microarray data revealed that sev-
eral canonical pathways (Cell cycle: G2/M DNA 
damage checkpoint; pyrimidine metabolism; Cell 
cycle: G1/S Checkpoint Regulation; and purine 
metabolism; insulin-like growth factor axis com-
ponents) were signiﬁ  cantly affected (Li et al. 2006). 
Figure 3. Butyrate treatment induced down regulation of MCM3 and 
ORC1 but has no effect on ORC2. Butyrate treated cells were 
extracted and proteins were separated on SDS PAGE. Western Blot 
analyses were performed with antibody against MCM3, ORC1 and 
ORC2. Western Blots from three experiments were quantiﬁ  ed with 
UN-SCAN-IT software (Silk Scientiﬁ  c, Orem, Utah. U.S.A). The relative 
densities were measured and corrected with the protein density. 
Density of control band is presented as 100% (n = 3 per treatment). 
Data was statistically analyzed by ANOVA using GraphPad Prism 
4.00 for Windows (GraphPad Software, San Diego, C.A., U.S.A). Data 
is presented as means +/− SEM. A) Normal cells were treated with 
or without butyrate. B) Cells were first synchronized by serum 
starvation for 72 hr (G1 phase) or released for 8 hrs after starvation 
(S phase) and then treated with or without butyrate. N: normal growing 
cells; G1: G1 phase cells; S: S phase cells.
Figure 4. Butyrate treatment induced up-regulation of p21 but has 
no effect on ERK1/2. Butyrate treated cells were extracted and pro-
teins were separated on SDS PAGE. Western Blot analyses were 
performed with antibody against p21 and ERK1/2. This ﬁ  gure is 
representative of two experiments. Western blot was quantiﬁ  ed with 
UN-SCAN-IT software (Silk Scientiﬁ  c, Orem, Utah. U.S.A). The relative 
densities were measured and corrected with the protein density. 
Density of control band is presented as 100%. Data was statistically 
analyzed by ANOVA using GraphPad Prism 4.00 for Windows 
(GraphPad Software, San Diego, C.A., U.S.A).120
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Interestingly, four pathways (Cell cycle: G2/M 
DNA damage checkpoint; pyrimidine metabolism; 
Cell cycle: G1/S Checkpoint Regulation; and 
purine metabolism) showed signiﬁ  cant down-
regulation. In addition, cell cycle checkpoint 
pathways (G2/M DNA damage checkpoint and 
G1/S Checkpoint regulation) are impaired due to 
the treatment of butyrate. Two pathways for criti-
cal regulation of purine and pyrimidine metabo-
lism were also linked to butyrate induced 
biological effects.
For the ﬁ  rst time, using microarray technique, 
MCM2, MCM3, MCM4, MCM5, MCM6 and 
ORC1, were found to be down-regulated by 
butyrate treatment (Table 3). In this study, we 
systematically investigated the expression 
regulation of selected DNA replication regulatory 
genes by butyrate using both real-time RT-PCR 
and Western blot analysis in bovine kidney epithe-
lial cells. These selected genes included cell cycle 
regulatory genes such as p21, CDC2/CDK1, as 
well as genes for DNA replication apparatus such 
as ORC1, ORC2 and MCM3. Overall trends indi-
cated there was a high correlation between mRNA 
expression and protein expression. The products 
of these genes all belong to pre-RC, which is a 
group of very important components of the DNA 
replication apparatuses. These proteins have been 
shown to be rate-limiting for the initiation of DNA 
replication in eukaryotic cell lines and are essential 
for the assembly of the pre-replication complex 
(Sun et al. 2002). Genes for MCM proteins 2, 3, 
4, 5, and 6, as well as ORC1 (Origin Recognition 
Complex largest subunit) are signiﬁ  cantly down-
regulated by butyrate, suggesting that in some way 
butyrate treatment directly targets genes which are 
essential for the initiation of DNA replication.
The eukaryotic ORC selects the genomic sites 
where pre-replication complexes are assembled 
and DNA replication begins. In spite of a signiﬁ  -
cant degree of conservation among ORC proteins 
from different eukaryotic sources, the regulation 
of their availability varies considerably in different 
model systems and cell types. Eukaryotic cells 
appear to regulate the assembly of functional ORC 
on chromatin sites through cell cycle-dependent 
modiﬁ  cations of one or more ORC subunits. ORC1 
has been identiﬁ  ed in previous studies as a primary 
control point in regulating the assembly of pre-
replication complexes on mammalian chromosomes. 
First, ubiquitination of ORC1 was found to be an 
important regulation mechanism of initiation of 
DNA replication (Li and DePamphilis, 2002; 
Mendez et al. 2002). Second, the role for CDK1 
(cyclin dependent protein kinase 1) /cyclin A in 
preventing the mammalian largest ORC subunit 
(Orc1) from binding to chromatin during mitosis 
was identiﬁ  ed (Li et al. 2004). More intriguing, 
our results from this study indicate that there is 
another mechanism for the regulation of the func-
tion of ORC1 at the levels of RNA transcription 
and protein translation, which can be induced by 
butyrate treatment. Expression of bovine ORC1 
gene is low after butyrate treatment, and the regu-
latory effects are dose dependent. In contrast, 
expression of bovine ORC2 and ORC3 genes do 
not appear to be similarly regulated. These results 
thus provide a direct link between the initiation of 
DNA replication and cell cycle arrest induced by 
butyrate. Moreover, ORC1 may be the most essen-
tial component of all replication complexes.
One universal feature of eukaryotic DNA rep-
lication is that the genome is replicated once and 
only once each time a cell divides. This is accom-
plished by restricting initiation events in at least 
two ways. First, pre-RCs that are assembled during 
the M to G1 phase transition are inactivated during 
S phase, and second, new pre-RCs cannot be 
assembled until G1 phase. In addition to blocking 
pre-RC assembly and activation at multiple steps 
such as the Cdc6, Cdt1, Mcm(2–7), and Cdk2 
functions, the premier step in determining both 
where and when DNA replication begins is the 
assembly of functional ORC/chromatin sites, and 
this step appears to be regulated by inactivating 
ORC during the G1 to S phase transition (Li and 
DePamphilis, 2002; Tatsumi et al. 2003) and then 
preventing re-establishment of ORC activity until 
mitosis is completed and, in the metazoan, a 
nuclear membrane is reassembled (Li et al. 2004; 
Tatsumi et al. 2000; Thome et al. 2000). Although 
these studies suggest that ORC activity in mam-
malian cells is regulated by cell-cycle-dependent 
Table 3. Butyrate-induced gene expression change in 
MDBK cells, validated by RT-PCR.
Genes Control  Butyrate
CDC2 1.10  ± 0.54  0.15 ± 0.03
CDKN1A (p21)  1.07 ± 0.48  3.02 ± 0.68
MCM6 1.03  ± 0.30  0.46 ± 0.26
ORC1L 1.04  ± 0.38  0.19 ± 0.06
ORC3L 1.04  ± 0.36  1.24 ± 0.50121
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changes in Orc1 function (ORC cycle), it has been 
suspected for a long time that histone acetylation 
may also affects the initiation of DNA replication 
(Brown et al. 1991; Lipford and Bell, 2001; 
Simpson, 1990). However, at present neither the 
enzymes nor the steps involved are known (Iizuka 
et al. 2006). Even though it is likely that other gene 
products targeted by butyrate treatment may play 
functional roles in the cell cycle arrest, our results 
reported here indicated that epigenetic constraints 
imposed by chromatin structure, such as hyper-
acetylation induced by butyrate, may regulate 
aspects of DNA replication and origin selection by 
ORC proteins at the levels of RNA transcription 
and protein translation of ORC1.
Cyclin/cdk inhibitor p21
waf1 is required for 
butyrate-mediated growth inhibition of human 
cancer cells. Butyrate and other SCFAs induce 
growth arrest in colon cancer cells through a pro-
cess requiring the induction of the G1 cell cycle 
inhibitor p21
waf1 (Archer et al. 1998). The activity 
of a variety of protein cyclins and their associated 
cyclin-dependent kinase (CDK) is required for the 
cell cycle progresses in mammalian cells. These 
Figure 5. An integrated network reﬂ  ecting the interaction of IGF2, extracellular matrix system and DNA replication Apparatus. Data set was 
analyzed by the Ingenuity Pathways Analysis software (Ingenuity
® Systems, www.ingenuity.com). The note color indicates the expression 
level of the genes (Red notes are up-regulated and green notes are down regulated). Notes and edges are displayed with various shapes 
and labels that present the functional class of genes and the nature of the relationship between the notes, respectively.122
Li and Li
Gene Regulation and Systems Biology 2008:2 
complexes are inhibited by cyclin/cdk inhibitor 
proteins such as p21
waf1. The balance between the 
activation and inhibition of cyclin-cdk activities 
determines the cell cycle progression. Since cancer 
cells are characterized by abnormalities in cell 
cycle regulation, our ﬁ  ndings indicate that p21
waf1 
may have a very similar function in both cancer 
cells and normal cells. It also underlies the 
possibility that in addition to the beneﬁ  cial effects 
of butyrate and other HDAC inhibitors, which 
induce growth arrest in colon cancer, it may also 
cause some side-effects on normal cells.
To determine the biologically relevant networks 
and pathways of the differentially expressed 
genes, pathway analysis was done using the Inge-
nuity Pathways Knowledge Base (Ingenuity
® 
Systems, www.ingenuity.com) (Li et al. 2006). 
One network identiﬁ  ed contains up-regulated 
IGF2, IGFBP3, INHBA, MMP1, MMP13, etc., 
as well as down-regulated genes such as IGFBP4, 
MCM2, MCM3, MCM4, MCM5, MCM6, and 
ORC1L. In a graphical representation of the 
molecular relationships between genes/gene 
products (Network Pathway) (Fig. 5), genes or 
gene products are represented as nodes, and the 
biological relationship between two nodes is 
represented as an edge (line). All edges are sup-
ported by at least 1 reference from the literature, 
from a textbook, or from canonical information 
stored in the Ingenuity Pathways Knowledge 
Base. Our network analysis identiﬁ  ed a complex 
network of genes involving IGF2, matrix metallo-
proteases (MMP1 and MMP13), TIMP3, IGFBPs 
as well as genes for DNA replication that are 
regulated by butyrate in MDBK cells.
In conclusion, the present ﬁ  ndings provide an 
example of epigenetic regulation of genome at 
work and a basis for understanding the full range 
of the biological roles and the molecular mecha-
nisms that butyrate may play in human and animal 
cell growth, proliferation, and energy metabolisms. 
The results illustrated the potentialities of nutri-
tional manipulation of gene activity for the purpose 
of enhancing animal health and production. This 
study has also generated comprehensive informa-
tion on the experimental system that can be used 
in many functional genomic studies in bovine and 
provided a basis for understanding the full range 
of the biological roles and the molecular mecha-
nisms that butyrate may play in animal cell growth, 
proliferation, and energy metabolism. More impor-
tantly, the present results suggest that Orc1, not 
Orc2 or Orc3, along with MCM proteins play a 
critical role in regulating the initiation of DNA 
replication and cell cycle progression in MDBK 
cells and are targets of butyrate regulation. All 
together, these ﬁ  ndings highlight key molecular 
mechanisms by which butyrate induces G1 cell 
cycle arrest in normal bovine cells. The results 
illustrate the potential to exploit nutritional 
manipulation of gene activity to enhance animal 
production efficiency in a drug residue-free 
format.
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